Search Results - Julie Ma, Guoguang

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    The potential for increased power from combining P-values testing the same hypothesis

    The potential for increased power from combining P-values testing the same hypothesis by Ganju, Jitendra, (Julie) Ma, Guoguang

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: Results from a randomized, double-blind, placebo-controlled trial in latin america

    Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting: Results from a randomized,... by POLI-BIGELLI, Sergio, RODRIGUES-PEREIRA, Jose, CARIDES, Alexandra D, MA, Guoguang Julie, ELDRIDGE, Krista, HIPPLE, Anita, EVANS, Judith K, HORGAN, Kevin J, LAWSON, Francesca

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Robust inference from multiple test statistics via permutations: a better alternative to the single test statistics approach for randomized trials

    Robust inference from multiple test statistics via permutations: a better alternative to the single test statistics approach for randomized trials by Ganju, Jitendra, Yu, Xinxin, Ma, Guoguang (Julie)

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Projecting adverse event incidence rates using empirical Bayes methodology

    Projecting adverse event incidence rates using empirical Bayes methodology by Ma, Guoguang (Julie), Ganju, Jitendra, Huang, Jing

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Robust inference from multiple test statistics via permutations: a better alternative to the single test statistic approach for randomized trials

    Robust inference from multiple test statistics via permutations: a better alternative to the single test statistic approach for randomized trials by Ganju, Jitendra, Yu, Xinxin, Ma, Guoguang (Julie)

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Variable Duration Trial as an Alternative Design for Continuous Endpoints

    Variable Duration Trial as an Alternative Design for Continuous Endpoints by Ganju, Jitendra, Ma, Julie Guoguang

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  7. 7
    Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin

    Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to... by Gralla, Richard J., de Wit, Ronald, Herrstedt, Jorn, Carides, Alexandra D., Ianus, Juliana, Guoguang‐Ma, Julie, Evans, Judith K., Horgan, Kevin J.

    Published in Cancer
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting

    Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy‐induced nausea and vomiting by Poli‐Bigelli, Sergio, Rodrigues‐Pereira, Jose, Carides, Alexandra D., Julie Ma, Guoguang, Eldridge, Krista, Hipple, Anita, Evans, Judith K., Horgan, Kevin J., Lawson, Francesca

    Published in Cancer
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  9. 9
    Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin : Analysis of combined data from two phase III randomized clinical trials

    Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to... by GRALLA, Richard J, DE WIT, Ronald, HERRSTEDT, Jorn, CARIDES, Alexandra D, IANUS, Juliana, GUOGUANG-MA, Julie, EVANS, Judith K, HORGAN, Kevin J

    Published in Cancer
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Assessing Similarity to Existing Drugs to Decide Whether to Continue Drug Development

    Assessing Similarity to Existing Drugs to Decide Whether to Continue Drug Development by Ma, Guoguang Julie, Chi, Eric, Ibrahim, Joseph G., Parker, Robert A.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  11. 11
    Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT 3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high‐dose cisplatin: Analysis of combined data from two phase III randomized clinical trials

    Antiemetic efficacy of the neurokinin‐1 antagonist, aprepitant, plus a 5HT 3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to... by Gralla, Richard J., de Wit, Ronald, Herrstedt, Jorn, Carides, Alexandra D., Ianus, Juliana, Guoguang‐Ma, Julie, Evans, Judith K., Horgan, Kevin J.

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: